Macy's, Inc.

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, DDS has a market cap of 7.8B. Regarding current trading prices, M is priced at $13.08, while DDS trades at $499.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas DDS's P/E ratio is 13.83. In terms of profitability, M's ROE is +0.13%, compared to DDS's ROE of +0.28%. Regarding short-term risk, M is more volatile compared to DDS. This indicates potentially higher risk in terms of short-term price fluctuations for M.Check DDS's competition here

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, JWN has a market cap of 4.1B. Regarding current trading prices, M is priced at $13.08, while JWN trades at $24.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas JWN's P/E ratio is 14.17. In terms of profitability, M's ROE is +0.13%, compared to JWN's ROE of +0.30%. Regarding short-term risk, M is more volatile compared to JWN. This indicates potentially higher risk in terms of short-term price fluctuations for M.Check JWN's competition here

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, KSS has a market cap of 1.4B. Regarding current trading prices, M is priced at $13.08, while KSS trades at $12.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas KSS's P/E ratio is 11.73. In terms of profitability, M's ROE is +0.13%, compared to KSS's ROE of +0.02%. Regarding short-term risk, M is less volatile compared to KSS. This indicates potentially lower risk in terms of short-term price fluctuations for M.Check KSS's competition here

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, EXTO has a market cap of 585.7M. Regarding current trading prices, M is priced at $13.08, while EXTO trades at $3.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas EXTO's P/E ratio is 90.25. In terms of profitability, M's ROE is +0.13%, compared to EXTO's ROE of +0.01%. Regarding short-term risk, M is less volatile compared to EXTO. This indicates potentially lower risk in terms of short-term price fluctuations for M.Check EXTO's competition here

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, DDT has a market cap of 408.9M. Regarding current trading prices, M is priced at $13.08, while DDT trades at $25.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas DDT's P/E ratio is N/A. In terms of profitability, M's ROE is +0.13%, compared to DDT's ROE of +0.25%. Regarding short-term risk, M is more volatile compared to DDT. This indicates potentially higher risk in terms of short-term price fluctuations for M.Check DDT's competition here

M plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, M stands at 3.6B. In comparison, CBD has a market cap of 218.1M. Regarding current trading prices, M is priced at $13.08, while CBD trades at $0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

M currently has a P/E ratio of 6.60, whereas CBD's P/E ratio is -14.83. In terms of profitability, M's ROE is +0.13%, compared to CBD's ROE of -0.55%. Regarding short-term risk, M is more volatile compared to CBD. This indicates potentially higher risk in terms of short-term price fluctuations for M.Check CBD's competition here